Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites

Molecules

Volumn 15, Issue 10, 2010, Pages 7197-7207

  Wang, Ying ^a   Cao, Ying Li ^a   Yang, Fan ^a   Zhang, Yun ^a   Wang, Shu Hui ^a   Liu, Li ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

EGFP; Membrane gene; RT PCR; SARS CoV; SiRNA

Indexed keywords

M PROTEIN, CORONAVIRUS; MATRIX PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL STRAIN HEK293; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; SARS CORONAVIRUS; SEQUENCE ALIGNMENT; VIRUS GENE;

BASE SEQUENCE; GENES, VIRAL; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SARS VIRUS; SEQUENCE ALIGNMENT; VIRAL MATRIX PROTEINS;

EID: 78149427988     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15107197     Document Type: Article

References (22)

1. Masters, P.S. The molecular biology of coronaviruses. Advan. Virus Res. 2006, 66, 193-292.
2. Frieman, M.; Baric, R. Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation. Microbiol. Mol. Biol. Rev. 2008, 72, 672-685.
3. Perlman, S.; Dandekar, A.A. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 2005, 5, 917-927.
4. Narayanan, K.; Huang, C.; Makino, S. SARS coronavirus accessory proteins. Virus Res. 2008, 133, 113-121.
5. Stertz, S.; Reichelt, M.; Spiegel, M.; Kuri, T.; Martinez-Sobrido, L.; Garcia-Sastre, A.; Weber, F.; Kochs, G. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 2007, 361, 304-315.
6. Huang, Y.; Yang, Z.Y.; Kong, W.P.; Nabel, G.J. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J. Virol. 2004, 78, 12557-12565.
7. Hsieh, P.K.; Chang, S.C.; Huang, C.C.; Lee, T.T.; Hsiao, C.W.; Kou, Y.H.; Chen, I.Y.; Chang, C.K.; Huang, T.H.; Chang, M.F. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J. Virol. 2005, 79, 13848-13855.
8. Siu, Y.L.; Teoh, K.T.; Lo, J.; Chan, C.M.; Kien, F.; Escriou, N.; Tsao, S.W.; Nicholls, J.M.; Altmeyer, R.; Peiris, J.S.; Bruzzone, R.; Nal, B. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J. Virol. 2008, 82, 11318-11330.
9. McBride, C.E.; Li, J.; Machamer, C.E. The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein. J. Virol. 2007, 81, 2418-2428.
10. Fang, X.; Ye, L.; Timani, K.A.; Li, S.; Zen, Y.; Zhao, M.; Zheng, H.; Wu, Z. Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus. J. Biochem. Mol. Biol. 2005, 38, 381-385.
11. Luo, H.; Wu, D.; Shen, C.; Chen, K.; Shen, X.; Jiang, H. Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction. Int. J. Biochem. Cell Biol. 2006, 38, 589-599.
12. Fang, X.; Gao, J.; Zheng, H.; Li, B.; Kong, L.; Zhang, Y.; Wang, W.; Zeng, Y.; Ye, L. The membrane protein of SARS-CoV suppresses NF-kappaB activation. J. Med. Virol. 2007, 79, 1431-1439.
13. Siu, K.L.; Kok, K.H.; Ng, M.H.; Poon, V.K.; Yuen, K.Y.; Zheng, B.J.; Jin, D.Y. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J. Biol. Chem. 2009, 284, 16202-16209.
14. Li, B.J.; Tang, Q.; Cheng, D.; Qin, C.; Xie, F.Y.; Wei, Q.; Xu, J.; Liu, Y.; Zheng, B.J.; Woodle, M.C.; Zhong, N.; Lu, P.Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 2005, 11, 944-951.
15. Qin, Z.L.; Zhao, P.; Cao, M.M.; Qi, Z.T. siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA. J. Virol. Methods 2007, 145, 146-154.
16. Shi, Y.; Yang, D.H.; Xiong, J.; Jia, J.; Huang, B.; Jin, Y.X. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Res. 2005, 15, 193-200.
17. Zhu, Y.; Liu, M.; Zhao, W.; Zhang, J.; Zhang, X.; Wang, K.; Gu, C.; Wu, K.; Li, Y.; Zheng, C.; Xiao, G.; Yan, H.; Guo, D.; Tien, P.; Wu, J. Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates. Virus Genes 2005, 30, 93-102.
18. Zheng, B.J.; Guan, Y.; Tang, Q.; Du, C.; Xie, F.Y.; He, M.L.; Chan, K.W.; Wong, K.L.; Lader, E.; Woodle, M.C.; Lu, P.Y.; Li, B.; Zhong, N. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. Antivir. Ther. 2004, 9, 365-374.
19. Lee, Y.N.; Chen, L.K.; Ma, H.C.; Yang, H.H.; Li, H.P.; Lo, S.Y. Thermal aggregation of SARS-CoV membrane protein. J. Virol. Methods 2005, 129, 152-161.
20. O'Neill, L.A.; Bowie, A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7, 353-364.
21. Sui, G.; Soohoo, C.; Affarel, B.; Gay, F.; Shi, Y.; Forrester, W.C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 2002, 99, 5515-5520.
22. Li, T.S.; Li, X.N.; Chang, Z.J.; Fu, X.Y.; Liu, L. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. Cell. Signal. 2006, 18, 1287-1298.